Salarius Pharmaceuticals, Inc.·4

Feb 13, 5:57 PM ET

Rosenblum Mark J 4

4 · Salarius Pharmaceuticals, Inc. · Filed Feb 13, 2020

Insider Transaction Report

Form 4
Period: 2020-02-13
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Purchase

    Common Stock

    2020-02-13$0.86/sh+5,000$4,2955,000 total

Documents

1 file
  • 4
    wf-form4_158163463653747.xmlPrimary

    FORM 4